Merck KGaA (OTCMKTS:MKGAF – Get Free Report)’s share price passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $174.19 and traded as low as $166.98. Merck KGaA shares last traded at $167.55, with a volume of 93 shares changing hands.
Merck KGaA Stock Up 2.2 %
The company has a 50-day moving average price of $174.19 and a 200 day moving average price of $167.70. The firm has a market capitalization of $21.65 billion, a PE ratio of 24.60 and a beta of 0.98. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.29 and a quick ratio of 0.82.
Merck KGaA (OTCMKTS:MKGAF – Get Free Report) last announced its quarterly earnings data on Wednesday, May 15th. The company reported $1.74 EPS for the quarter, missing the consensus estimate of $1.92 by ($0.18). Merck KGaA had a net margin of 13.09% and a return on equity of 11.61%. The business had revenue of $5.56 billion during the quarter. Analysts forecast that Merck KGaA will post 9.73 earnings per share for the current year.
About Merck KGaA
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
See Also
- Five stocks we like better than Merck KGaA
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- BlackBerry Stock: Strong Earnings, Profitability Challenges Ahead
- How to Find Undervalued Stocks
- Progress Software Stock Back in the Green After Beating Forecasts
- What Are Dividend Contenders? Investing in Dividend Contenders
- Goldman Sachs Raises Stock Target for Affirm: Key Insights
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.